Memory B cell-guided extended interval dosing of ocrelizumab in multiple sclerosis. Meng D, Sacco R, Disanto G, Widmer F, et al. Mult Scler 2024 May 20:13524585241250199. doi: 10.1177/13524585241250199.

Read + Share

Amedeo Smart

Independent Medical Education

Meng D, Sacco R, Disanto G, Widmer F, et al. Memory B cell-guided extended interval dosing of ocrelizumab in multiple sclerosis. Mult Scler 2024 May 20:13524585241250199. doi: 10.1177/13524585241250199.
PMID: 38767224